What is SonoVascular?
SonoVascular operates as a clinical-stage medical device enterprise dedicated to the development of sophisticated ultrasound-based thrombectomy systems. The company's core technology platform is engineered to treat both venous and arterial blood clots with high precision. By integrating therapeutic ultrasound, microbubbles, and targeted drug delivery, the platform is designed to clear clot burden effectively while prioritizing the preservation of vessel health. This unique approach places SonoVascular at the intersection of interventional cardiology and vascular surgery, offering a potentially transformative solution for patients suffering from acute thrombotic conditions. The company's focus on clinical validation and technological refinement underscores its role as a high-potential player in the medical technology sector.
How much funding has SonoVascular raised?
SonoVascular has raised a total of $6M across 1 funding round:
Series A
$6M
Series A (2026): $6M with participation from Harbright Ventures
Key Investors in SonoVascular
Harbright Ventures
Harbright Ventures is an investment firm focused on fueling the growth of innovative companies that create positive impacts on people and the planet, with a specific interest in medical technology and B2B SaaS.
What's next for SonoVascular?
With the recent capital influx, SonoVascular is well-positioned to transition from its current development phase toward more rigorous clinical trials and regulatory milestones. The strategic investment will likely be deployed to scale manufacturing capabilities, expand the clinical research team, and initiate the necessary studies to secure regulatory clearance for its catheter platform. As the company moves forward, the focus will remain on demonstrating the safety and efficacy of its ultrasound-based system in real-world clinical settings. Investors and industry stakeholders will be closely monitoring the firm's progress as it navigates the complex landscape of medical device commercialization, aiming to disrupt traditional thrombectomy procedures with its specialized, minimally invasive technology.
See full SonoVascular company page
